Poland· PL-100000729
Neomycinum Jelfa
A neomycin product containing neomycini sulfas, registered in Poland by Bausch+Lomb Ireland Ltd.. The same ATC class is registered in 3 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Neomycin is registered in 3 of 19 countries.
Countries holding a registration under ATC S01AA03 (neomycin), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 2 of them publish a price we can compare per daily dose
Neomycin · ATC S01AA03
3 / 19 countries
- Finlandprice
- Polandprice
- United Kingdom
The record
At a glance
URPL (Poland)- Active substance
- Neomycini sulfas
- Manufacturer
- Bausch+Lomb Ireland Ltd.
- Country
- Poland (PL)
- ATC code
- S01AA03
- ATC class
- Neomycin
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909990790913
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Neomycin in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesAntibioticTotal Resources International
- United KingdomCicatrin creamGlaxoSmithKline UK Ltd
- BelgiumPanotileZambon
- GermanyMyacyneMaxmedic Pharma Gmbh.
- CanadaNEOPRO 325CAN-VET ANIMAL HEALTH SUPPLIES LTD.
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Germany · Myacyne, Neomycinsulfat Smartpractice Europe
- Spain · Neomicina
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dd19cffa-429a-4ac5-a7b4-f005d9761005 GET /v1/drugs/dd19cffa-429a-4ac5-a7b4-f005d9761005?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Maść do oczu",
"source": "urpl",
"strength": "5 mg/g",
"packaging": "05909990790913 ¦ Rp ¦ 45978\n1 tuba 3 g",
"substance": "Neomycini sulfas 5 mg/g",
"common_name": "Neomycini sulfas",
"pl_product_id": "100000729",
"pozwolenie_nr": "07909",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about neomycin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.